Bartter syndrome is a rare inherited kidney disorder that disrupts the normal reabsorption of salt in the thick ascending limb of the loop of Henle, a segment of the kidney's filtering tubules. The faulty salt transport forces the kidneys to waste sodium, potassium, and chloride, which the body partly compensates for by producing more of the hormones that regulate blood pressure and fluid balance; the result is a distinctive pattern of low blood potassium, an alkaline blood pH, and blood pressure that stays normal or low despite the hormonal activity. Genetic mutations in several different genes can cause the condition, each affecting a different protein involved in salt transport along the nephron, which has led physicians to classify Bartter syndrome into five genetic types, from mutations in the sodium-potassium-chloride cotransporter gene SLC12A1 in type 1 to mutations in the calcium-sensing receptor gene CASR in type 5. A related but generally milder inherited salt-wasting disorder, Gitelman syndrome, affects a different part of the same kidney tubule system. The syndrome is named for the American endocrinologist Frederic Bartter, who together with Pacita Pronove first described it in 1960, with additional case reports following in 1962.
Facts
Classification
ICD-10 ChapterIV: Endocrine, Nutritional and Metabolic Diseases 2 Communicable or Non-communicable Causative Agent
Causative Agent (category) First Described Sources
1. Bartter syndrome (Wikipedia)
lead sentence 1
Bartter syndrome (BS) is a rare inherited disease characterised by a defect in the thick ascending limb of the loop of Henle, which results in low potassium levels (hypokalemia), increased blood pH (alkalosis), and normal to low blood pressure.
Lead: disease category
Bartter syndrome (BS) is a rare inherited disease characterised by a defect in the thick ascending limb of the loop of Henle, which results in low potassium levels (hypokalemia), increased blood pH (alkalosis), and normal to low blood pressure.
History section
Pacita Pronove, first described it in 1960 and in more patients in 1962.
View the Source2. World Health Organization: ICD-10 Version:2019 - E26.8
World Health OrganizationICD-10 2019 category E26.8, Chapter IVQuote, ICD-10 2019 category E26.8, Chapter IV
E26.8 Other hyperaldosteronism Incl.: Bartter syndrome
View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.